GAPDH and gastric cancer: In addition, the mRNA levels of TFF2/GAPDH in gastric cancer tissues were significantly lower than those in the corresponding non-neoplastic mucosal tissues (mean ± SE, 3.4±2.7 vs. 9.6±5.4, respectively; P=0.046) (Fig. 1B).